[PDF][PDF] Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation
F Dentali, N Riva, M Crowther, AGG Turpie, GYH Lip… - 2012 - Citeseer
Background—Novel oral anticoagulants (NOACs) have been proposed as alternatives to
vitamin K antagonists for the prevention of stroke and systemic embolism in patients with …
vitamin K antagonists for the prevention of stroke and systemic embolism in patients with …
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.
F Dentali, N Riva, M Crowther, AG Turpie, GY Lip… - Circulation, 2012 - europepmc.org
Background Novel oral anticoagulants (NOACs) have been proposed as alternatives to
vitamin K antagonists for the prevention of stroke and systemic embolism in patients with …
vitamin K antagonists for the prevention of stroke and systemic embolism in patients with …
[PDF][PDF] Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation
F Dentali, N Riva, M Crowther, AGG Turpie, GYH Lip… - 2012 - academia.edu
Background—Novel oral anticoagulants (NOACs) have been proposed as alternatives to
vitamin K antagonists for the prevention of stroke and systemic embolism in patients with …
vitamin K antagonists for the prevention of stroke and systemic embolism in patients with …
[引用][C] Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature
F DENTALI - Circulation, 2012 - cir.nii.ac.jp
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review
and meta-analysis of the literature | CiNii Research CiNii 国立情報学研究所 学術情報 …
and meta-analysis of the literature | CiNii Research CiNii 国立情報学研究所 学術情報 …